SE430159B - Analogiforfarande for framstellning av nya piperidinderivat - Google Patents
Analogiforfarande for framstellning av nya piperidinderivatInfo
- Publication number
- SE430159B SE430159B SE7713906A SE7713906A SE430159B SE 430159 B SE430159 B SE 430159B SE 7713906 A SE7713906 A SE 7713906A SE 7713906 A SE7713906 A SE 7713906A SE 430159 B SE430159 B SE 430159B
- Authority
- SE
- Sweden
- Prior art keywords
- preparing new
- analogy procedure
- piperide
- ingredients
- piperide ingredients
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/78—Ring systems having three or more relevant rings
- C07D311/80—Dibenzopyrans; Hydrogenated dibenzopyrans
- C07D311/82—Xanthenes
- C07D311/84—Xanthenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 9
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Anesthesiology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Furan Compounds (AREA)
- Pyrane Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU76RI605A HU174215B (hu) | 1976-12-15 | 1976-12-15 | Sposob poluchenija novykh proizvodnykh piperazina i kislotnykh additivnykh i chetvjortichnykh solej |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| SE7713906L SE7713906L (sv) | 1978-06-16 |
| SE430159B true SE430159B (sv) | 1983-10-24 |
Family
ID=11001009
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE7713906A SE430159B (sv) | 1976-12-15 | 1977-12-07 | Analogiforfarande for framstellning av nya piperidinderivat |
Country Status (21)
| Country | Link |
|---|---|
| US (2) | US4140790A (sv) |
| JP (2) | JPS6026114B2 (sv) |
| AT (1) | AT359507B (sv) |
| BE (1) | BE861849A (sv) |
| CA (1) | CA1080219A (sv) |
| CH (1) | CH632750A5 (sv) |
| DE (1) | DE2755707A1 (sv) |
| ES (1) | ES465061A1 (sv) |
| FI (1) | FI65427C (sv) |
| FR (1) | FR2374322A1 (sv) |
| GB (1) | GB1580227A (sv) |
| HU (1) | HU174215B (sv) |
| IL (1) | IL53552A (sv) |
| IN (1) | IN146474B (sv) |
| NL (1) | NL7713827A (sv) |
| NO (1) | NO147306C (sv) |
| PT (1) | PT67403B (sv) |
| SE (1) | SE430159B (sv) |
| SU (1) | SU694071A3 (sv) |
| YU (1) | YU293677A (sv) |
| ZA (1) | ZA777398B (sv) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU174215B (hu) * | 1976-12-15 | 1979-11-28 | Richter Gedeon Vegyeszet | Sposob poluchenija novykh proizvodnykh piperazina i kislotnykh additivnykh i chetvjortichnykh solej |
| US4703120A (en) * | 1986-04-28 | 1987-10-27 | Ortho Pharmaceutical Corporation | Furo(3,4-d)pyrimidine-2,4-dione derivatives and intermediates thereof |
| CN1060168C (zh) * | 1994-05-06 | 2001-01-03 | 中国人民解放军军事医学科学院毒物药物研究所 | 新的呫吨衍生物，其制备方法及含它们的药物组合物 |
| CN101607958A (zh) | 2002-02-01 | 2009-12-23 | 阿斯特拉曾尼卡有限公司 | 喹唑啉化合物 |
| EP1611116A2 (en) * | 2003-04-08 | 2006-01-04 | Neuromed Technologies, Inc. | Calcium channel inhibitors comprising benzhydril spaced from piperazine |
| US20080207738A1 (en) * | 2007-02-28 | 2008-08-28 | Cancure Laboratories, Llc | Drug combinations to treat drug resistant tumors |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3481930A (en) * | 1966-11-21 | 1969-12-02 | American Home Prod | Xanthene and thioxanthene-9 ureas and propionamides |
| US3502662A (en) * | 1968-03-18 | 1970-03-24 | American Home Prod | N-(9-xanthenyl or thioxanthenyl)-3-amino or iodo-propionamides and 4-(9-xanthenyl or thioxanthenyl)-thiosemicarbazones |
| FR2201084B1 (sv) * | 1972-09-29 | 1975-10-31 | Bouchara Emile | |
| GB1437868A (en) * | 1973-05-09 | 1976-06-03 | Synthelabo | Arylpiperazinoalkyl esters |
| HU174215B (hu) * | 1976-12-15 | 1979-11-28 | Richter Gedeon Vegyeszet | Sposob poluchenija novykh proizvodnykh piperazina i kislotnykh additivnykh i chetvjortichnykh solej |
-
1976
- 1976-12-15 HU HU76RI605A patent/HU174215B/hu unknown
-
1977
- 1977-11-25 JP JP52140843A patent/JPS6026114B2/ja not_active Expired
- 1977-12-02 CH CH1475877A patent/CH632750A5/de not_active IP Right Cessation
- 1977-12-05 AT AT867677A patent/AT359507B/de not_active IP Right Cessation
- 1977-12-06 IL IL53552A patent/IL53552A/xx unknown
- 1977-12-07 SE SE7713906A patent/SE430159B/sv unknown
- 1977-12-09 FR FR7737196A patent/FR2374322A1/fr active Granted
- 1977-12-12 YU YU02936/77A patent/YU293677A/xx unknown
- 1977-12-12 US US05/859,928 patent/US4140790A/en not_active Expired - Lifetime
- 1977-12-12 FI FI773743A patent/FI65427C/fi not_active IP Right Cessation
- 1977-12-12 IN IN1717/CAL/77A patent/IN146474B/en unknown
- 1977-12-12 ZA ZA00777398A patent/ZA777398B/xx unknown
- 1977-12-13 SU SU772555706A patent/SU694071A3/ru active
- 1977-12-14 CA CA293,096A patent/CA1080219A/en not_active Expired
- 1977-12-14 ES ES465061A patent/ES465061A1/es not_active Expired
- 1977-12-14 GB GB52038/77A patent/GB1580227A/en not_active Expired
- 1977-12-14 PT PT67403A patent/PT67403B/pt unknown
- 1977-12-14 BE BE183452A patent/BE861849A/xx not_active IP Right Cessation
- 1977-12-14 JP JP14945477A patent/JPS5377073A/ja active Pending
- 1977-12-14 NO NO774294A patent/NO147306C/no unknown
- 1977-12-14 DE DE19772755707 patent/DE2755707A1/de not_active Ceased
- 1977-12-14 NL NL7713827A patent/NL7713827A/xx not_active Application Discontinuation
-
1978
- 1978-12-28 US US05/974,082 patent/US4250310A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| FI773743A (fi) | 1978-06-16 |
| IL53552A (en) | 1981-07-31 |
| FR2374322B1 (sv) | 1981-11-27 |
| US4250310A (en) | 1981-02-10 |
| FI65427C (fi) | 1984-05-10 |
| YU293677A (en) | 1982-08-31 |
| SE7713906L (sv) | 1978-06-16 |
| ZA777398B (en) | 1978-10-25 |
| ES465061A1 (es) | 1979-01-01 |
| JPS5377080A (en) | 1978-07-08 |
| NL7713827A (nl) | 1978-06-19 |
| BE861849A (fr) | 1978-03-31 |
| IL53552A0 (en) | 1978-03-10 |
| FI65427B (fi) | 1984-01-31 |
| HU174215B (hu) | 1979-11-28 |
| SU694071A3 (ru) | 1979-10-25 |
| US4140790A (en) | 1979-02-20 |
| JPS5377073A (en) | 1978-07-08 |
| DE2755707A1 (de) | 1978-06-29 |
| IN146474B (sv) | 1979-06-16 |
| FR2374322A1 (fr) | 1978-07-13 |
| PT67403A (en) | 1978-01-01 |
| NO147306C (no) | 1983-03-16 |
| PT67403B (en) | 1979-05-21 |
| NO774294L (no) | 1978-06-16 |
| ATA867677A (de) | 1980-04-15 |
| NO147306B (no) | 1982-12-06 |
| CH632750A5 (de) | 1982-10-29 |
| CA1080219A (en) | 1980-06-24 |
| JPS6026114B2 (ja) | 1985-06-21 |
| GB1580227A (en) | 1980-11-26 |
| AT359507B (de) | 1980-11-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE442400B (sv) | Forfarande for framstellning av nya 1-aryloxi-2-hydroxi-3-alkylenaminopropaner | |
| SE431753B (sv) | Analogifprfarande for framstellning av 2-piperazinyl-6,7-dimetoxikinazoliner | |
| SE430601B (sv) | Analogiforfarande for framstellning av nya dipeptidderivat | |
| SE440501B (sv) | Forfarande for framstellning av substituerade fenylamidoximer | |
| SE434057B (sv) | Forfarande for framstellning av nya rifamycinforeningar | |
| SE7703715L (sv) | Framstellning av nya aminokromanoler | |
| SE440772B (sv) | Forfarande for framstellning av nya 1-naftylmetyl-cinnamyl-aminderivat | |
| NO773548L (no) | Fremgangsmaate for fremstilling av spiro-hydantoinderivater | |
| SE437515B (sv) | Forfarande for framstellning av nya fenyletylaminer | |
| FI772915A (fi) | Foerfarande foer framstaellning av nya antracyklinantibiotika | |
| SE420314B (sv) | Analogiforfarande for framstellning av indolizinderivat | |
| SE426833B (sv) | Forfarande for framstellning av nya gona-4,9(10)-diener | |
| SE7704545L (sv) | Forfarande for framstellning av nya adeninderivat | |
| SE438856B (sv) | Analogiforfarande for framstellning av 1-acyloximetyl-3-fluoruracilderivat | |
| SE431871B (sv) | Forfarande for framstellning av 2-brom-6-fluor-n-2-imidazolidinylidenbensamin | |
| SE7704139L (sv) | Forfarande for framstellning av azofergemnen | |
| SE436566B (sv) | Analogiforfarande for framstellning av nya fenetylaminderivat | |
| SE7614264L (sv) | Forfarande for framstellning av nya 17-estrar av 17alfa-hydroxigestogener | |
| SE433220B (sv) | Forfarande for framstellning av nya pregnan-derivat | |
| SE7703634L (sv) | Forfarande for framstellning av nya amidinopenicillanoyloxialkylamoxicillinater | |
| SE440903B (sv) | Forfarande for framstellning av nya 1-aryloxi-2-hydroxi-3-aminopropaner | |
| SE421125B (sv) | Forfarande for framstellning av 5-m-tolyloxiuracil | |
| SE431336B (sv) | Analogiforfarande for framstellning av substituerade 8-azapurinderivat | |
| SE7700824L (sv) | Forfarande for framstellning av nya kromaner | |
| SE430159B (sv) | Analogiforfarande for framstellning av nya piperidinderivat |